Literature DB >> 18480337

Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile.

Michael Gerber1, Christiane Walch1, Birgit Löffler1, Kristin Tischendorf1, Udo Reischl2, Grit Ackermann1.   

Abstract

Clostridium difficile is the major cause of hospital-acquired infectious diarrhoea. Several antimicrobials are known to induce and promote C. difficile-associated diarrhoea (CDAD). The impact of metronidazole (MTR), vancomycin (VAN), clindamycin (CLI) and linezolid (LZD) on growth, toxin gene transcription and toxin production in C. difficile was investigated. Four C. difficile strains were grown with and without sub-MIC concentrations of MTR, VAN, CLI and LZD (0.5x MIC) and growth was measured by colony counts. Toxin production was detected using ELISA (for toxin A) and a cytotoxicity assay (for toxin B) in culture supernatants and also in sonicated cells. Real-time PCR was used to measure transcription of the toxin A and B genes. The aim of this work was to combine analysis of toxin A and B production by ELISA or cell culture assay with transcriptomic analysis. The four strains showed similar growth and different levels of toxin production in the absence of antibiotics. An antibiotic-free control showed toxin production at a late stage when the plateau phase of bacterial growth was reached, whereas antibiotic-exposed strains showed earlier toxin production. All of the antibiotics used except CLI increased the transcription rate of toxin genes. The findings of this study show that sub-MIC concentrations of antibiotics can cause changes in gene transcription of the major virulence factors of C. difficile. This study describes a new method for transcriptomic analysis of toxin genes in C. difficile.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480337     DOI: 10.1099/jmm.0.47739-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  22 in total

1.  Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile.

Authors:  Michael John Aldape; Dustin Delaney Heeney; Amy Evelyn Bryant; Dennis Leroy Stevens
Journal:  J Antimicrob Chemother       Date:  2014-08-23       Impact factor: 5.790

Review 2.  Elfamycins: inhibitors of elongation factor-Tu.

Authors:  Samantha M Prezioso; Nicole E Brown; Joanna B Goldberg
Journal:  Mol Microbiol       Date:  2017-08-09       Impact factor: 3.501

Review 3.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

4.  Subinhibitory concentrations of LFF571 reduce toxin production by Clostridium difficile.

Authors:  Meena Sachdeva; Jennifer A Leeds
Journal:  Antimicrob Agents Chemother       Date:  2014-12-15       Impact factor: 5.191

5.  Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile.

Authors:  Michael John Aldape; Aaron Eugene Packham; Drew William Nute; Amy Evelyn Bryant; Dennis Leroy Stevens
Journal:  J Med Microbiol       Date:  2013-02-21       Impact factor: 2.472

6.  Anti-Sense Antibiotic Agents as Treatment for Bacterial Infections.

Authors:  David B Stewart
Journal:  Surg Infect (Larchmt)       Date:  2018-09-25       Impact factor: 2.150

7.  Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains.

Authors:  Cécile Denève; Sylvie Bouttier; Bruno Dupuy; Frédéric Barbut; Anne Collignon; Claire Janoir
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

8.  In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.

Authors:  Hans H Locher; Peter Seiler; Xinhua Chen; Susanne Schroeder; Philippe Pfaff; Michel Enderlin; Axel Klenk; Elvire Fournier; Christian Hubschwerlen; Daniel Ritz; Ciaran P Kelly; Wolfgang Keck
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

9.  Benzyl and benzoyl benzoic acid inhibitors of bacterial RNA polymerase-sigma factor interaction.

Authors:  Jiqing Ye; Adrian Jun Chu; Lin Lin; Shu Ting Chan; Rachel Harper; Min Xiao; Irina Artsimovitch; Zhong Zuo; Cong Ma; Xiao Yang
Journal:  Eur J Med Chem       Date:  2020-08-18       Impact factor: 6.514

10.  The multifaceted roles of antibiotics and antibiotic resistance in nature.

Authors:  Saswati Sengupta; Madhab K Chattopadhyay; Hans-Peter Grossart
Journal:  Front Microbiol       Date:  2013-03-12       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.